Thursday, June 20, 2019

Potential Risk of Variant Creutzfeldt-Jakob Disease (vCJD) From Plasma-Derived Products

In recent years, questions have been raised concerning the potential risk of variant Creutzfeldt-Jakob disease (vCJD - a rare but fatal brain infection) for recipients of plasma- derived clotting factors.

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2Lcw03p

No comments:

Post a Comment